# Outset Medical (OM.US)

Canonical: https://gigainvestors.com/s/OM

Analysis as of: 2026-10-16T07:30:53.092Z. 

Listing currency: USD. Reporting currency: USD.

## Verdict

Not enough history yet

Quality tests for Buy: not passed (profit record: fail; earnings resilience is evidence only). Published buy qualification: no.

Share price: $4.08 per share; close as of 2026-10-15.

## Checklist

### understandable: na

### moat: na

### economics: na

### management: na

### accounting: na

## Holders

## Price story

Down 92% since Oct 2021

Story as of 2026-10-16T10:01:29.725Z; price observation 2026-10-15.

## Owner memo

Memo as of 2026-10-16T08:06:05.509Z.

### How it makes money

Operates in medical devices; annual sales are USD 119.5 million.

- Source: https://www.sec.gov/Archives/edgar/data/1484612/000119312526051278/om-20251231.htm (filed 2026-02-13); FY2025: revenue 119476000; grossProfit 46754000; margin = grossProfit / revenue.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-05); OM.US: Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

### Why customers stay

Margins ranged from 22.2% to 39.1% during 2023–25.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-02-13); FY2023: grossProfit / revenue = 22.2%.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-02-13); FY2024: grossProfit / revenue = 33.9%.

- Source: https://www.sec.gov/Archives/edgar/data/1484612/000119312526051278/om-20251231.htm (filed 2026-02-13); FY2025: grossProfit / revenue = 39.1%.

### Where the cash goes

Paid no dividends in 6 years.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-02-13); Dividend observations: [[2020,0],[2021,0],[2022,0],[2023,0],[2024,0],[2025,0]]. Zero only counted when supported by a complete cash-flow statement.

### What the price says

The price is less than 0.1 times annual sales; cash earnings are negative.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-02-13); Closing price 4.08 USD; reporting-to-trading FX 1; FY2025 annual sales per share 7854.578923147722; price multiple 0.0005194422310756973. FY2025 cash earnings/share -5135.099598974426. Closing-price date 2026-10-15.

## Monthly share-price history (USD per share)

- 2020-09: $50.00 per share

- 2020-10: $46.47 per share

- 2020-11: $64.00 per share

- 2020-12: $56.84 per share

- 2021-01: $51.83 per share

- 2021-02: $49.79 per share

- 2021-03: $54.39 per share

- 2021-04: $59.92 per share

- 2021-05: $48.27 per share

- 2021-06: $49.98 per share

- 2021-07: $40.96 per share

- 2021-08: $49.29 per share

- 2021-09: $49.44 per share

- 2021-10: $53.27 per share

- 2021-11: $47.40 per share

- 2021-12: $46.09 per share

- 2022-01: $37.19 per share

- 2022-02: $43.97 per share

- 2022-03: $45.40 per share

- 2022-04: $34.88 per share

- 2022-05: $21.80 per share

- 2022-06: $14.86 per share

- 2022-07: $15.45 per share

- 2022-08: $18.29 per share

- 2022-09: $15.93 per share

- 2022-10: $15.54 per share

- 2022-11: $21.08 per share

- 2022-12: $25.82 per share

- 2023-01: $28.12 per share

- 2023-02: $22.81 per share

- 2023-03: $18.40 per share

- 2023-04: $17.99 per share

- 2023-05: $20.83 per share

- 2023-06: $21.87 per share

- 2023-07: $20.58 per share

- 2023-08: $13.61 per share

- 2023-09: $10.88 per share

- 2023-10: $3.54 per share

- 2023-11: $5.24 per share

- 2023-12: $5.41 per share

- 2024-01: $3.04 per share

- 2024-02: $3.15 per share

- 2024-03: $2.22 per share

- 2024-04: $2.53 per share

- 2024-05: $3.73 per share

- 2024-06: $3.85 per share

- 2024-07: $3.55 per share

- 2024-08: $0.53 per share

- 2024-09: $0.68 per share

- 2024-10: $0.57 per share

- 2024-11: $0.90 per share

- 2024-12: $1.11 per share

- 2025-01: $0.80 per share

- 2025-02: $0.73 per share

- 2025-03: $11.06 per share

- 2025-04: $10.64 per share

- 2025-05: $17.57 per share

- 2025-06: $19.21 per share

- 2025-07: $16.06 per share

- 2025-08: $13.91 per share

- 2025-09: $14.12 per share

- 2025-10: $13.12 per share

- 2025-11: $4.56 per share

- 2025-12: $3.71 per share

- 2026-01: $5.01 per share

- 2026-02: $3.49 per share

- 2026-03: $3.84 per share

- 2026-04: $4.27 per share

- 2026-05: $4.89 per share

- 2026-06: $4.32 per share

- 2026-07: $4.57 per share

- 2026-08: $3.82 per share

- 2026-09: $3.00 per share

- 2026-10: $4.08 per share

## Annual estimated value (USD per share)

Historical values use today's bond yield for every fiscal year

Historical values use today's FX rate into trading currency for every fiscal year

Historical values use current restated fundamentals and current commodity classification; they are not point-in-time estimates

## Sources

[Original 10-K filing](https://www.sec.gov/Archives/edgar/data/1484612/000119312526051278/om-20251231.htm); period 2025-12-31, filed 2026-02-13.

Estimates depend on assumptions and are not guarantees or investment advice. Underlying data remains subject to its source licenses; public reading does not grant bulk redistribution rights.

## Reported holder observations



# OM — Outset Medical Inc.

Held by 1 investor · USD 14,454,729 total · 2025 Q3 · reported price USD 14.12 (split-adjusted).
Page: https://gigainvestors.com/s/OM

## Holders (2025 Q3)

| Investor | Value | % of their portfolio | This quarter |
|---|---:|---:|---|
| Henry Ellenbogen (https://gigainvestors.com/DCP) | USD 14,454,729 | 0.1% | reduce -38.22% |

## Total held by quarter

- 2020 Q3: USD 2,750,013 · 1 holder · USD 750.14
- 2020 Q4: USD 3,125,998 · 1 holder · USD 852.70
- 2021 Q1: USD 2,991,016 · 1 holder · USD 815.88
- 2021 Q2: USD 2,748,987 · 1 holder · USD 749.86
- 2021 Q3: USD 2,718,999 · 1 holder · USD 741.68
- 2021 Q4: USD 2,535,002 · 1 holder · USD 691.49
- 2022 Q1: USD 0 · 0 holders
- 2022 Q2: USD 0 · 0 holders
- 2022 Q3: USD 0 · 0 holders
- 2022 Q4: USD 0 · 0 holders
- 2023 Q1: USD 0 · 0 holders
- 2023 Q2: USD 0 · 0 holders
- 2023 Q3: USD 0 · 0 holders
- 2023 Q4: USD 0 · 0 holders
- 2024 Q1: USD 0 · 0 holders
- 2024 Q2: USD 0 · 0 holders
- 2024 Q3: USD 0 · 0 holders
- 2024 Q4: USD 0 · 0 holders
- 2025 Q1: USD 19,246,789 · 1 holder · USD 11.06
- 2025 Q2: USD 31,833,390 · 1 holder · USD 19.21
- 2025 Q3: USD 14,454,729 · 1 holder · USD 14.12
- 2025 Q4: USD 0 · 0 holders